{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T19:36:21Z","timestamp":1715974581095},"reference-count":36,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2011,8,18]],"date-time":"2011-08-18T00:00:00Z","timestamp":1313625600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Exper Ophthalmology"],"published-print":{"date-parts":[[2012,1]]},"abstract":"<jats:title>A<jats:sc>bstract<\/jats:sc><\/jats:title><jats:p><jats:bold>Background:\u2002<\/jats:bold> To describe the changes in retinal vascular calibre in response to intravitreal ranibizumab injections in patients with neovascular age\u2010related macular degeneration.<\/jats:p><jats:p><jats:bold>Design:\u2002<\/jats:bold> Prospective interventional case series.<\/jats:p><jats:p><jats:bold>Participants:\u2002<\/jats:bold> Treatment na\u00efve patients with neovascular age\u2010related macular degeneration were recruited over a 1\u2010year period.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Each patient received three monthly intravitreal injections according to a \u2018loading dose\u2019. Retinal arteriolar and venular calibre was measured from digital fundus photographs and summarized as central retinal artery equivalent and central retinal vein equivalent at baseline and 3\u2003months.<\/jats:p><jats:p><jats:bold>Main Outcome Measure:\u2002<\/jats:bold> Central retinal artery equivalent and central retinal vein equivalent changes from baseline to 3\u2003months.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Seventy\u2010four eyes of 71 patients had good quality images for grading vessel calibre at baseline and at 3\u2003months in treated (study) eyes and 51 eyes of 51 patients had good quality images in fellow (control) eyes. Over 3\u2003months, in study eyes treated with ranibizumab, there was a significant increase in central retinal vein equivalent over baseline (+6.20\u2003\u00b5m, <jats:italic>P<\/jats:italic>\u2003=\u20030.005), but no significant change in central retinal artery equivalent (+0.86\u2003\u00b5m, <jats:italic>P<\/jats:italic>\u2003=\u20030.55). In control eyes, there was no change in central retinal vein equivalent (\u22120.82\u2003\u00b5m, <jats:italic>P<\/jats:italic>\u2003=\u20030.70) or central retinal artery equivalent (0.34\u2003\u00b5m, <jats:italic>P<\/jats:italic>\u2003=\u20030.75).<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Intravitreal ranibizumab has a significant vasodilational effect on retinal venular calibre in eyes treated for neovascular age\u2010related macular degeneration. The reason for this change is unclear, but may relate to changes in blood flow or inflammatory changes within the retina.<\/jats:p>","DOI":"10.1111\/j.1442-9071.2011.02613.x","type":"journal-article","created":{"date-parts":[[2011,6,13]],"date-time":"2011-06-13T19:26:37Z","timestamp":1307993197000},"page":"59-66","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Retinal venular calibre dilatation after intravitreal ranibizumab treatment for neovascular age\u2010related macular degeneration"],"prefix":"10.1111","volume":"40","author":[{"given":"Sanjeewa S","family":"Wickremasinghe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn H","family":"Guymer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tien Y","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanling","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salmaan","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,8,18]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.03.008"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062655"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2006.00736.x"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.04-1050"},{"key":"e_1_2_5_6_2","first-page":"385","article-title":"Foveolar choroidal blood flow in age\u2010related macular degeneration","volume":"39","author":"Grunwald JE","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_5_7_2","first-page":"3158","article-title":"VEGF is major stimulator in model of choroidal neovascularization","volume":"41","author":"Kwak N","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_5_8_2","first-page":"2115","article-title":"Constitutive expression of VEGF, VEGFR\u20101, and VEGFR\u20102 in normal eyes","volume":"40","author":"Kim I","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)61231-X"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.061237"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003554"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.05-1229"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2008.09.002"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.07-099481"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-0731"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00133.2005"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2008.10.003"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.03.017"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.09-3721"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.08.063"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(13)38012-9"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90525-0"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.09.039"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1076\/ceyr.27.3.143.16049"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-1450"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200410001-00002"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2009.11.003"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.06.045"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.05-1539"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/129873"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1998.00262.x"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2010.03.023"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.05.007"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-007-0660-z"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181a2c1c3"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2008.07.006"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.09.012"}],"container-title":["Clinical &amp; Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1442-9071.2011.02613.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1442-9071.2011.02613.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T05:23:03Z","timestamp":1698729783000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1442-9071.2011.02613.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,18]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["10.1111\/j.1442-9071.2011.02613.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1442-9071.2011.02613.x","archive":["Portico"],"relation":{},"ISSN":["1442-6404","1442-9071"],"issn-type":[{"value":"1442-6404","type":"print"},{"value":"1442-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,18]]},"assertion":[{"value":"2011-08-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}